| ARDS | Acute respiratory distress syndrome |
| ADE | Antibody-dependent enhancement |
| SARS-Cov-2 | Severe acute respiratory syndrome coronavirus 2 |
| COVID-19 | Novel Coronavirus disease-2019 |
| 3CLpro | Coronavirus main proteinase |
| ACE2 | Angiotensin-converting Enzyme 2 |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| Cov | Coronavirus |
| dsRNA | Double strand RNA |
| DPP4 | Dipeptidyl-peptidase 4 |
| ERGIC | ER-Golgi intermediate compartment |
| EBOV | Ebola virus |
| gRNA | Guide RNA |
| GSK3 | Glycogen synthase kinase 3 |
| hM-RNAP | Human mitochondrial RNA polymerase |
| Orf1 | Open reading frame 1 |
| PLpro | Papain-like protease |
| MERS | Middle East Respiratory Syndrome |
| MPO | Myeloperoxidase |
| NTD | N-terminal domain |
| NMBA | Neuromuscular blocking agents |
| NHC | β-D-N4-hydroxycytidine |
| N protein | Coronavirus nucleoproteins |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| RBD | Receptor-binding domain |
| RT-PCR | Reverse transcription PCR |
| SARS | Severe Acute Respiratory Syndrome |
| S protein | Spike glycoprotein |
| ssRNA | Single strand RNA |
| SPR | Surface plasmon resonance |
| SKP2 | S-phase kinase-associated protein 2 |
| SpO2 | Peripheral capillary oxygen saturation |
| RdRp | RNA-dependent RNA Polymerase |
| RBD | Receptor-binding domain |
| TMPSS2 | Transmembrane protease serine 2 |
| TATs | Trioxa-adamantane-triols |
| UPR | Unfolded protein response |
| VLPs | Virus-like particles |